Prokidney Corp. PROK
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
What this company does
Written from the business description in ProKidney Corp.'s annual report to the U.S. Securities and Exchange Commission, filed 18 March 2026. Every sentence was checked against that document before publication.
Growth
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
No chart to show — the reason differs by year; see each year in the table below.
Return on equity has no reading this year — return on capital employed, just below, still does: -47%.
The 6-year record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 | 0.0 | ◌ | ◌ |
| Operating income $B | −0.2 | −0.2 | −0.2 | −0.2 | −0.1 | −0.0 |
| EBITDA $B | −0.2 | −0.2 | −0.1 | −0.1 | −0.1 | −0.0 |
| Income tax $B | 0.0 | −0.0 | 0.0 | 0.0 | 0.0 | −0.0 |
| Net income $B | −0.1 | −0.1 | −0.0 | −0.1 | −0.1 | −0.0 |
| Free cash flow $B | −0.1 | −0.2 | −0.1 | −0.1 | −0.1 | −0.0 |
| EPS, diluted $ | ◌ | ◌ | ◌ | −0.23 | ◌ | ◌ |
| Dividend / sh $ | ◌ | ◌ | ◌ | ◌ | ◌ | ◌ |
| Payout % — not applicable: no dividend | — | — | — | — | — | — |
| ROE % | — | — | — | — | −299.9 | ◌ |
Slide the table for earlier years. "—" not applicable · "◌" not available in our data.
Company facts, as filed
Reconciled in 5 of the 6 fiscal years we could check. 28 checks were skipped: the balance sheet is not tagged before 2021. 15 checks were skipped: EPS is not tagged before 2022.